Yeast Adhesion in the Pathogenesis of Endocarditis Due to Candida albicans: Studies with Adherence-Negative Mutants

Two spontaneous cerulenin-resistant mutants of Candida albicans, 4918-2 and 4918-10, were unable to adhere in vitro in fibrin-platelet clots. Because in vitro adherence correlates well with colonization of nonbacterial thrombotic endocarditis on traumatized valvular endocardium, 50% infectious dose...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 152; no. 4; pp. 710 - 715
Main Authors Calderone, Richard A., Cihlar, Ronald L., Lee, D. Dong-Soo, Hoberg, Kathryn, ScheId, W. Michael
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.10.1985
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Two spontaneous cerulenin-resistant mutants of Candida albicans, 4918-2 and 4918-10, were unable to adhere in vitro in fibrin-platelet clots. Because in vitro adherence correlates well with colonization of nonbacterial thrombotic endocarditis on traumatized valvular endocardium, 50% infectious dose studies were performed with a rabbit model of endocarditis. Wild-type C. albicans required 103.6 ± 0.12 cfu in comparison with 105.73 ± 0.31 and 107.3 ± 0.21 cfu for mutants 4918-2 and 4918-10, respectively. The relative avirulence of mutant strains in producing endocarditis was not attributed to accelerated clearance of these strains from the bloodstream. In fact, clearance of wild-type and mutant strains was almost identical. In the same animals renal candidiasis was observed with all strains of C. albicans, although the number of cfu per gram of kidney was higher after infection with wild-type C. albicans. Thus, strains of C. albicans with reduced ability to adhere in vitro to a fibrin-platelet matrix are relativelyavirulent in the rabbit endocarditis model.
Bibliography:This research was supported by Public Health Service grant NIH-HL-21370 from the National Heart, Lung, and Blood Institute to Dr. Calderone. Dr. Scheld is the recipient of Clinical Investigator Award K08-00517 from the National Institute of Allergy and Infectious Diseases.
istex:12E48744A636A2F58D15BACA42450DCEC93110EB
ark:/67375/HXZ-G88S93V7-F
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/152.4.710